ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag court genetics genomics

Genome patents need purpose
Andrea Gawrylewski | Aug 4, 2008 | 2 min read
The British High Court's rejection linkurl:last week;http://www.the-scientist.com/blog/display/54909/ of a biotech company's patent on the genetic sequence coding for a therapeutically important protein may be a warning for other biotechs who hold patents on portions of the human genome. The court ruled last week that a patent held by Human Genome Sciences since the mid 1990s was invalid because at the time the company applied for the patent they hadn't demonstrated a practical use. The patent
Will Genomics Spoil Gene Ownership?
Douglas Steinberg | Sep 3, 2000 | 8 min read
Consider a scenario for the year 2002: Using commercially available software, bioprospector "Craig Collins" spends a day scavenging the Human Genome Project (HGP) database for the alternatively spliced genes prized by Wall Street. He enters the sequences of several candidate genes into a software package that prints out the likely functions of their protein products. One protein looks like it could be pharmaceutical paydirt, so he isolates the corresponding cDNA, inserts it into a vector, then
Privatizing the Human Genome?
Paul Smaglik | Jun 7, 1998 | 10 min read
Principals behind joint-venture proposal and public effort seek to define relationships A private effort to sequence the human genome four years ahead of the Human Genome Project's 2005 goal could either compete directly with the federal project or meld seamlessly with it. Before any relationship between the two efforts becomes formalized, scientists and federal officials involved with the Human Genome Project must determine whether the private approach will work, who will own the data, how qu
The Scientist Staff | Mar 28, 2024
The Biggest Stories in Bioscience 2005
Ishani Ganguli | Dec 4, 2005 | 8 min read
Life scientists have been challenged more than ever this year not just to critically analyze data, but to better interpret those data for an increasingly critical public.
Sly Guys
The Scientist | Jul 1, 2014 | 10+ min read
Across the animal kingdom, dominance isn’t the only way for a male to score. Colluding, sneaking around, or cross-dressing can work, too.
Fighting Fraud With DNA
Bennett Daviss | Jun 20, 2004 | 8 min read
Next time you buy a designer shirt, be sure to check the label. What you don't see may surprise you. Hidden within the ink or fibers of that shirt could lie an authentication device made not of plastic or metal, but of DNA."DNA has become the gold standard, the highest barrier to product counterfeiting, diversion, and piracy," says Julia Hunter, executive vice president of Applied DNA Sciences in Los Angeles. In this case, though, the term gold is both literal and figurative. The International C
Biotech Faces Evolving Patent System
Douglas Steinberg | Mar 5, 2000 | 8 min read
Like medieval alchemists, modern biologists apply intricate, esoteric protocols to lowly matter, such as bacteria and rodents. Unlike alchemists, biologists successfully transmute these creatures into gold--disease-fighting pharmaceuticals and profits accruing from them. An indispensable ingredient in this dross-to-drug process is patent protection, which preserves monopoly and attracts investment. Unfortunately, the patent system isn't as ideal a catalyst as the chimerical philosopher's stone s
Patents On Some Science Findings Would Present Problems
Dorothy Nelkin | Nov 22, 1992 | 5 min read
Date: November 23, 1992 Editor's Note: Indications are that the National Institutes of Health's controversial gene-patenting initiative, now widely seen as moribund, is really as good as dead. At press time, a final decision on the matter was still in the hands of Secretary of Health and Human Services Louis Sullivan, but sources at HHS feel the initiative is on insecure legal footing and will be dropped. Before the proposal more or less gave up its ghost, however, it served to stimulate anim
Notebook
The Scientist Staff | Sep 1, 1997 | 7 min read
Table of Contents More Newsworthy Sheep Grade Strike Earns an F Brain Drain Sexual Chemistry Cheaper Journals Michign Misconduct Matters Lucky 7 Cloning BRCA2 Credit: Graham G. Ramsay ON THE LAMB: Dario Fauza performed fetal surgery on ovine patients. While Dolly the cloned sheep has yet to disappear from the headlines, other ovines have made medical history. Dario Fauza, a fellow at Harvard Medical School and Children's Hospital in Boston, along with Anthony Atala, an assistant professor of

Run a Search

ADVERTISEMENT